Owlet Strengthens Healthcare Partnerships: Can Adoption Scale?

Core Insights - Owlet, Inc. (OWLT) is enhancing its healthcare partnerships to broaden adoption beyond traditional consumer channels, aiming to expand use cases for its monitoring products and improve long-term visibility in regulated environments [1][11] Group 1: Healthcare Partnerships - The company's strategy focuses on collaborating with healthcare systems and retail healthcare partners to engage with parents and caregivers earlier in the care journey, supporting use cases beyond routine at-home monitoring [2] - In Q3 2025, Owlet launched a consignment agreement with the Children's Hospital of the King's Daughters, marking the first instance of Owlet devices being prescribed in a hospital setting, allowing for insurance prior authorization and continued home monitoring [3] - Owlet is also pursuing additional hospital partnerships to replicate this model, while continuing to work with retail healthcare partners to enhance access and awareness [4][11] Group 2: Competitive Landscape - The connected infant monitoring and digital health market is highly competitive, with companies like Masimo and iRhythm Technologies influencing adjacent segments [6] - Masimo is recognized for its medical-grade pulse oximetry and patient monitoring, emphasizing the technical complexity and investment needed for high-quality devices [7] - iRhythm Technologies provides a comparison in remote cardiac monitoring, showcasing how a combination of devices and long-term services can foster sustained engagement [8] Group 3: Market Performance and Estimates - Owlet's shares have increased by 75.1% over the past six months, outperforming the Zacks Electronics-Miscellaneous Products industry's growth of 42.5% and the Zacks Computer and Technology sector's rise of 16.2% [10] - The Zacks Consensus Estimate for OWLT's 2026 loss per share has improved to 25 cents from 88 cents over the past 60 days, with an expected loss of 12 cents per share in 2025 [13]